These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6986968)
61. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275). Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814 [TBL] [Abstract][Full Text] [Related]
62. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma. Presant CA; Ratkin G; Klahr C Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389 [No Abstract] [Full Text] [Related]
64. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate. Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937 [TBL] [Abstract][Full Text] [Related]
65. Methyl-CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma. Richards F; Cooper MR; Muss HB; White DR; Spurr CL Cancer; 1976 Sep; 38(3):1077-82. PubMed ID: 953956 [TBL] [Abstract][Full Text] [Related]
66. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study. Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204 [TBL] [Abstract][Full Text] [Related]
67. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine]. Roth A; Kolarić K Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141 [No Abstract] [Full Text] [Related]
68. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma. O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870 [TBL] [Abstract][Full Text] [Related]
69. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma. Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274 [No Abstract] [Full Text] [Related]
70. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278). Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866 [TBL] [Abstract][Full Text] [Related]
71. Chemotherapy of large intestinal carcinoma. Current results and future prospects. Schein PS; Kisner D; MacDonald JS Cancer; 1975 Dec; 36(6 Suppl):2418-20. PubMed ID: 764960 [TBL] [Abstract][Full Text] [Related]
72. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer. Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316 [No Abstract] [Full Text] [Related]
74. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233 [TBL] [Abstract][Full Text] [Related]
75. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer]. Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917 [TBL] [Abstract][Full Text] [Related]
76. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [TBL] [Abstract][Full Text] [Related]
77. Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma. Kemeny N; Reichman B; Geller N; Hollander P Am J Clin Oncol; 1988 Feb; 11(1):66-72. PubMed ID: 2963534 [TBL] [Abstract][Full Text] [Related]
78. [Chemotherapy protocol for metastasizing colorectal carcinoma. Methotrexate, 5-fluorouracil and cytarabine]. Dias Wickramanayake P; Klein HO; Pape S; Meyer-Hofmann H Dtsch Med Wochenschr; 1985 Mar; 110(13):487-91. PubMed ID: 3979285 [TBL] [Abstract][Full Text] [Related]
79. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. De Lena M; Brambilla C; Morabito A; Bonadonna G Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104 [TBL] [Abstract][Full Text] [Related]
80. A controlled clinical trial testing two potentially non-cross-resistant chemotherapeutic regimens in small-cell carcinoma of the lung. Broder LE; Selawry OS; Charyulu KN; Ng A; Bagwell S Chest; 1981 Mar; 79(3):327-35. PubMed ID: 6258871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]